ABL Bio
298380.KQ
45.31 USD
-2.71
-5.64%
a
Overview
Last close
45.31 usd
Market cap
2.18B usd
52 week high
48.81 usd
52 week low
14.77 usd
Target price
48.5 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
97.3815
Price/Book Value
20.1672
Enterprise Value
2.23B usd
EV/Revenue
96.4085
EV/EBITDA
-32.1061
Key financials
Revenue TTM
23.14M usd
Gross Profit TTM
23.10M usd
EBITDA TTM
-39.47M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
157.38M usd
Net debt
N/A usd
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.
- Symbol298380.KQ
- ExchangeKQ
- IsinKR7298380007
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Sang Hoon Lee Ph.D.
- HeadquarterSeongnam-si
- Web sitehttps://www.ablbio.com
